point-of-care-diagnostics-or-testing-market

Point-Of-Care Diagnostics / Testing (POCT) Market By Product (Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Hematology Testing, Blood Gas Testing), By End-User (Clinics, Home, Laboratories, Assisted Living Healthcare Facilities, Hospitals) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2024

26 Apr 2016 Format PDF icon PPT icon XLS icon Request Sample

This report on point-of-care diagnostics / testing (POCT) market studies various products and end-users market. POCT is considered as one of the most affordable technologies of global diagnostics market, and development in POCT technologies over period of time has been carried out through innovations in smart and portable bio-sensor, computing, and information and communication technologies. According to market experts the factors assisting the growth of POC diagnostics market are several government initiatives have aided in the development of innovative outpatient care models, to minimize hospital stays and rapidly increasing demand for home healthcare globally.

For the purpose of this study, the global point of care diagnostics market on the basis of product type is segmented into glucose monitoring,  urinalysis testing, cardiac markers , infectious diseases testing,  cholesterol testing, coagulation monitoring , pregnancy and fertility testing, hematology testing, fecal occult testing kits, blood gas testing, cancer markers, drugs of abuse testing, and others . Market size estimates and forecast for these segments for the period 2013 to 2023 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2023, considering 2015 as the base year.

On the basis of end users point of care diagnostic market is segmented as clinics, home, laboratories, assisted living healthcare facilities and hospitals. The diagnostic tests performed on a large scale in these healthcare institutes and increasing demand for further expansion of point of care diagnostic facilities are the key factors fueling the growth of point of care diagnostics market in hospitals and clinics. Market size estimates and forecast for these segments for the period 2013 to 2023 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2023, considering 2015 as the base year.

The POC diagnostics and testing market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2013 to 2023 and their CAGRs for the period 2016 to 2023 are provided in this report.

The key manufacturers from point of care diagnostics market are carrying out constant efforts and huge investments on research and development of innovative products which are enabled with advanced technologies. The major key players profiled in the POC diagnostics and testing market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Roche Diagnostics Ltd., Alere Inc., Siemens AG, and Beckman Coulter, Inc., Johnson & Johnson, Bayer AG, and Abbott Laboratories, Abaxis, Inc., Becton, Dickinson And Company, and Nipro Diagnostics, Inc.

In year 2015, the glucose monitoring segment accounted for the largest market share in the POCT market. The incidences and prevalence of diabetes and the requirement of regular measurement of sugar levels in the blood are the key factors driving the point of care glucose monitoring market. According to International Diabetes Federation (IDF), the number of people living with the disease is expected to soar to 552 million by 2030 -- equating to three new cases every 10 seconds -- up from 366 million in 2011. However, the rapid diagnostics market and OTC is expected to show lucrative growth over the forecast period owing to the rising demand for early disease diagnosis and self-diagnosis to instigate immediate and on-time treatment of chronic diseases.

In base year 2015, the clinics and hospitals collectively attribute the largest share in the market in terms of revenue. The diagnostic tests are carried out on a large scale in these healthcare institutes and rising demand for accessible and patient compliant diagnostics technologies are the key factors fueling the growth of POC diagnostics market in hospitals and clinics. Moreover, the aging patient base worldwide and rising demand of assisted and home healthcare technologies, the point of care diagnostic market is expected to show lucrative growth over the forecast period 2016 - 2023.

In base year 2015, North America accounted for the largest share in the global POCT market, followed by Asia-Pacific, Europe, and the RoW (Rest of the World). The Asia-Pacific region (comprising Japan, China and India as major countries) is anticipated to grow at the fastest CAGR during the forecast period 2016 - 2023. The key factors assisting the growth of point-of-care diagnostics market in Asia-Pacific region are the huge patient population base, large number of R&D activities carried out in diagnostics field, rising focus of both international and domestic players on the Asia-Pacific POCT market, and increasing funding/investment towards the development of Point-Of-Care Diagnostics / Testing products.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Point-Of-Care Diagnostics / Testing (POCT) market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Point-Of-Care Diagnostics / Testing (POCT) market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE DETAILS
Research Period  2022-2032
Base Year 2023
Forecast Period  2024-2032
Historical Year  2022
Unit  USD Million
Segmentation
Products
  • Glucose Monitoring
  • Cardiac Markers
  • Infectious Diseases Testing
  • Cholesterol Testing
  • Coagulation Monitoring
  • Pregnancy And Fertility Testing
  • Hematology Testing
  • Blood Gas Testing
  • Others (Fecal Occult Testing, Cancer Markers, Urinalysis Testing, Drugs Of Abuse Testing, etc.)

End-users
  • Clinics
  • Home
  • Laboratories
  • Assisted living healthcare facilities
  • Hospitals

 Region Segment (2022-2032; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Point-Of-Care Diagnostics / Testing (POCT) market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2032.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Point-Of-Care Diagnostics / Testing (POCT) market?
  • Which is the largest regional market for Point-Of-Care Diagnostics / Testing (POCT) market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Point-Of-Care Diagnostics / Testing (POCT) market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Point-Of-Care Diagnostics / Testing (POCT) market worldwide?
Choose Licence Type
$4325
$6325
$12650
Why Acute
View Other Reports